The American Psychiatric Association annual meeting, gathering live for the first time since 2019, will be in New Orleans May 21-25. The first sold-out session was a day-long seminar on treating opioid use disorder (OUD) with buprenorphine, conducted by new APA president Petros Levounis, M.D., an addiction medicine physician, and colleagues. Levounis is professor and chair of the Department of Psychiatry and associate dean for professional development at Rutgers New Jersey Medical School, and the chief of service at University Hospital in Newark, New Jersey. He was director of the Addiction Institute of New York from 2002 to 2013, and completed his fellowship in addiction psychiatry at New York University. For more information about the meeting, which will also be streamed online June 7-10, go to https://psychiatry.org/psychiatrists/meetings/annual-meeting/guide. Dr. Levounis received his medical education at Stanford University School of Medicine and the Medical College of Pennsylvania and his training in psychiatry at the New York State Psychiatric Institute of Columbia University. He completed his fellowship in addiction psychiatry at New York University. With Louis Baxter, M.D. and colleagues, he authored “Safe methadone induction and stabilization: Report of an expert panel, published in the Journal of Addiction Medicine in 2013. The popularity of the buprenorphine session shows how thirsty psychiatrists are for information on how to treat their patients with OUD.